Skip to content

The clinical and basic research for the CD8+ Tem cell proliferation and differentiation mediated by mTOR signaling pathway to improve the immune response in sepsis

The clinical and basic research for the CD8+ Tem cell proliferation and differentiation mediated by mTOR signaling pathway to improve the immune response in sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17010750
Enrollment
Unknown
Registered
2017-02-28
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

bacterial infection:none
mixed infection:none
fungal infection:none

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Enrolled patients should be older than 18 years of age with confirmed or presumed infection, that they met two or more criteria for systemic inflammatory response syndrome and that there was evidence of refractory hypotension or serum lactate greater than 2 mmol per liter. Refractory hypotension was defined as systolic blood pressure below 90 mm Hg or mean arterial pressure (MAP) below 65 mm Hg after an intravenous fluid challenge of 30 ml or more per kilogram of body weight. All the patients will be from ICU of Peking Union Medical College Hospital.

Exclusion criteria

Exclusion criteria: age younger than 18 years, pregnancy, or giving up on treatment.

Design outcomes

Primary

MeasureTime frame
T-bet;Eomes;Granzyme B;Perforin;IFN;IL-2;IL-6;IL-7;IL-12;mTOR;S6K;

Countries

China

Contacts

Public ContactCui Na

Department of Critical Care Medicine, Peking Union Medical College Hospital

CuiNa@pumch.cn+86 15601212623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026